Asymmetry Capital Management Lowers stake in QUEST DIAGNOSTICS INC COM (DGX)

QUEST DIAGNOSTICS INC COM (DGX) : Asymmetry Capital Management reduced its stake in QUEST DIAGNOSTICS INC COM by 31.94% during the most recent quarter end. The investment management company now holds a total of 63,595 shares of QUEST DIAGNOSTICS INC COM which is valued at $4,788,704 after selling 29,850 shares in QUEST DIAGNOSTICS INC COM , the firm said in a disclosure report filed with the SEC on Apr 21, 2016.QUEST DIAGNOSTICS INC COM makes up approximately 11.32% of Asymmetry Capital Management’s portfolio.

QUEST DIAGNOSTICS INC COM opened for trading at $75.54 and hit $76 on the upside on Wednesday, eventually ending the session at $75.72, with a gain of 0.03% or 0.02 points. The heightened volatility saw the trading volume jump to 10,94,515 shares. Company has a market cap of $10,810 M.

Other Hedge Funds, Including , Raymond James Trust N.a. reduced its stake in DGX by selling 1,887 shares or 20.49% in the most recent quarter. The Hedge Fund company now holds 7,324 shares of DGX which is valued at $551,497. QUEST DIAGNOSTICS INC COM makes up approx 0.05% of Raymond James Trust N.a.’s portfolio.Cornerstone Advisors reduced its stake in DGX by selling 7 shares or 21.21% in the most recent quarter. The Hedge Fund company now holds 26 shares of DGX which is valued at $1,958.Marshwinds Advisory Co reduced its stake in DGX by selling 150 shares or 2.04% in the most recent quarter. The Hedge Fund company now holds 7,200 shares of DGX which is valued at $523,080. QUEST DIAGNOSTICS INC COM makes up approx 0.27% of Marshwinds Advisory Co’s portfolio.

On the company’s financial health, QUEST DIAGNOSTICS INC COM reported $1.12 EPS for the quarter, based on the information available during the earnings call on Apr 21, 2016. Analyst had a consensus estimate of $1.12. The company had revenue of $1863.00 million for the quarter, compared to analysts expectations of $1823.36 million. The company’s revenue was up 1.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.05 EPS.

Many Wall Street Analysts have commented on QUEST DIAGNOSTICS INC COM. Company shares were Reiterated by RBC Capital Mkts on Apr 22, 2016 to “Sector Perform”, Firm has raised the Price Target to $ 76 from a previous price target of $70 .Company shares were Reiterated by Barclays on Apr 22, 2016 to “Equal Weight”, Firm has raised the Price Target to $ 75 from a previous price target of $72 .Company shares were Reiterated by Mizuho on Apr 21, 2016 to “Buy”, Firm has raised the Price Target to $ 84 from a previous price target of $75 .

Quest Diagnostics Incorporated is a provider of diagnostic testing information services. The Company consists of two businesses: Diagnostic Information Services and Diagnostic Solutions. Diagnostic Information Services business consists of two parts develops and delivers diagnostic testing information and services to patients physicians health plans hospitals accountable care organizations (ACOs) integrated delivery networks (IDNs) other commercial laboratories patients and other customers. Diagnostics Information Services business also provides diagnostic information services which includes providing clinical testing services such as routine testing gene-based and esoteric testing anatomic pathology services and drugs-of-abuse testing. Diagnostic Solutions includes the Company’s other businesses including central laboratory testing for pharmaceutical and medical device clinical trials risk assessment services diagnostic products and healthcare information technology.

Leave a Reply

QUEST DIAGNOSTICS INC COM - Is it time to Sell?

Top Brokerage Firms are advising their investors on QUEST DIAGNOSTICS INC COM. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.